Latest Regulatory News

Nordic Resources (ASX:NNL) has reported new drill results extending gold-copper mineralisation 30-100m beyond the current resource boundary at its Kopsa project in Finland, with geophysical data suggesting depth continuity. The company plans further drilling and a resource update in 2026.

Alcoa Corporation delivered a record quarterly revenue of $4 billion in Q2 2026, boosted by strong aluminium prices and operational restarts, while advancing a major acquisition of South32’s upstream assets.

SkyCity Entertainment Group has completed the unconditional sale of its 99 Albert Street and Victoria Street properties for $74.5 million, aiming to reduce debt and boost financial flexibility.

Titomic Limited updates investors that its planned shift of corporate domicile from Australia to the US is still underway but the timeline has slipped, with a revised schedule expected by late July or August 2026.

Richmond Vanadium Technology has appointed Seth McCann as General Manager for Development, Approvals & Studies, positioning the company to advance critical environmental and regulatory milestones for its Queensland vanadium project.

North Stawell Minerals (ASX:NSM) highlights a robust gold exploration pipeline in Victoria, anchored by an upgraded 87,300-ounce Wildwood resource and promising high-grade prospects along the Darlington-Caledonia trend.

Comet Ridge Limited has pushed back the closing date for its Share Purchase Plan and associated Options Offers to 24 July 2026, giving eligible shareholders more time to participate ahead of a key August meeting.

Javelin Minerals' latest RC drilling at Eureka in WA affirms shallow high-grade gold continuity and extends mineralisation along strike, with resource open down-plunge and key permits secured.

CGN Resources has bolstered its position in the Leonora gold district by acquiring the 142 km² Desdemona Project, expanding its landholding to 386 km². The company has initiated its first reverse circulation drilling program at Christmas Well targeting multiple high-priority gold prospects.

AMP Limited has lifted its underlying net profit after tax (NPAT) guidance for the first half of 2026 to $170 million-$180 million, driven by stronger China partnerships and recognition of carried interest from legacy asset sales.

TrivarX has locked in investigational product supply critical for starting its Phase 1 clinical trial of the Stabl-Im MRI imaging platform, targeting a 2026 trial commencement.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.